Skip to main content

Table 1 Some clinical and laboratory data of both studied groups

From: Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study)

Parameter   NAFLD patients Controls P- value
   (No = 47) (No = 23)  
Age Mean ± SD 11.13 ± 2.7 10.6 ± 3.1 0.43
Sex Male (%) 19 (40.4 %) 9 (39.1 %) 0.32
  Female (%) 28 (59.6 %) 14 (60.9 %)  
BMI centile (th) Mean ± SD 96.8723 ± 0.5 92.2 ± 9.3 <0.001*
ALT (U/L) Mean ± SD 63.8 ± 31.1 27.6 ± 5.7 <0.001*
AST (U/L) Mean ± SD 58.8 ± 22.9 28.8 ± 8.7 <0.001*
GGT (U/L) Mean ± SD 53.8 ± 21.6 34.5 ± 9.4 <0.001*
Serum albumin (mg/dl) Mean ± SD 3.5 ± 0.52 3.9 ± 0.2 <0.001*
Total bilirubin (mg/dl) Mean ± SD 1.4 ± 0.71 0.71 ± 0.2 <0.001*
Direct bilirubin (mg/dl) Mean ± SD 0.32 ± 0.2 0.14 ± 0.05 <0.001*
Alkaline phosphatase (U/L) Mean ± SD 214.4 ± 56.6 186.2 ± 46.4 0.01*
CRP (mg/dl) Mean ± SD 56 ± 18.1 5 ± 3.1 <0.001*
Serum creatinine (mg/dl) Mean ± SD 0.81 ± 0.35 1 ± 0.19 <0.001*
Serum cholesterol (mg/dl) Mean ± SD 198.3 ± 27.1 163.8 ± 27.5 <0.001*
Serum triglyceride (mg/dl) Mean ± SD 191.3 ± 37.6 157.7 ± 32.9 <0.001*
Serum LDL (mg/dl) Mean ± SD 104.7 ± 36.2 108.13 ± 11.1 0.52
Serum HDL (mg/dl) Mean ± SD 37.3 ± 9.7 43.4 ± 8.1 0.002*
Fasting Blood glucose (mg/dl) Mean ± SD 143.3 ± 33.9 100.17 ± 14.7 <0.001*
Fasting insulin (mU/ml) Mean ± SD 11.7 ± 4.8 4.5 ± 2.9 <0.001*
HOMA-IR Mean ± SD 76.6 ± 41.4 20.7 ± 16.3 <0.001
Serum 25(OH) D (nmol/L) Mean ± SD 52.1 ± 41.3 104.7 ± 36.2 <0.001*
  1. *Significant (p value <0.05), BMI body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma glutamyl transferase, CRP C reactive protein, LDL Low density lipoprotein, HDL High density lipoprotein, HOMA-IR homeostasis model assessment index for insulin resistance and 25(OH)D 25 hydroxy vitamin D